Large International Study of COPD Drug Finds Two Types of Inhalers Equally Safe and Effective - 9/9/13

An international study led by a Johns Hopkins pulmonary expert finds that the drug tiotropium, marketed as the Spiriva brand, can be delivered safely and effectively to people with chronic obstructive pulmonary disease - COPD - in both mist and traditional dry powder inhalers.
Source: Johns Hopkins Medicine News - Category: Research Source Type: news